We are delighted to share the announcement that Greg Hamilton has been appointed as the new Chief Executive Officer of Accellix, Inc. Greg’s extensive background in molecular diagnostics and life science tools coupled with years of strategic leadership experience makes him the perfect fit to lead Accellix into its next phase of growth.
With over 25 years of experience, Greg has a proven track record of driving innovation and success. His leadership will be pivotal as Accellix continues to expand its impact in the cell therapy and blood bank markets.
Join us in congratulating Greg on this new role! We are eager to see the achievements that lie ahead for Accellix under his guidance.
